|
|
|
|
| Advertisement |
 |
|
|
| Washington |
|
|
Presidential Candidates & Rx Policy |
As the nation heads towards its first presidential primaries of the 2016 election, pharmaceutical executives should take a few minutes to consider where the leading candidates stand on U.S. Rx policy.
... /Read more/ |
|
|
|
|
| Executive Profile |
 |
|
Ferring: The Quiet Company
|
Ferring's Michel Pettigrew on finding new medical uses for peptide hormones and the company's ambitions to scale up globally by applying cutting-edge research at all stages of the product life cycle.
... /Read more/ |
|
|
| Regulatory |
|
|
mAbs to Watch in 2016
|
Of the 45 new molecular entities and new therapeutic biological products approved by FDA in 2015, nine products were monoclonal antibodies (mAbs).
... /Read more/ |
|
|
|
|
|
|
